1-5 of 5 results
-
Achieve Ultra-Sensitive MRD Detection with AccuScan and DNBSEQ™ Technology
Cell-free DNA (cfDNA) sequencing for minimal residual disease (MRD) detection is limited by errors in library preparation and sequencing. Replacing traditional PCR with Rolling Circle Replication (RCR) in both steps, using AccuScan for preparation and DNBSEQ for sequencing, reduces errors significantly. -
Complete Genomics and Parse Biosciences showcase high quality end-to-end single cell sequencing solutions
The study compared Complete Genomics DNBSEQ-G400 and Illumina NovaSeq 6000 on single-RNA libraries from Vevo Therapeutics’ cancer cell lines, prepared using Parse Biosciences kits. DNBSEQ-G400 showed comparable or better single-cell sequencing results than NovaSeq 6000. -
Low duplication rates and high-complexity exome analysis with twist exome 2.0 panel and DNBSEQ-G400 sequencing platform
NGS technology allows for cost-effective, high-resolution detection of genetic variations related to diseases. Essential for research and genetic services, it balances quality and costs using methods like whole genome sequencing (WGS), whole exome sequencing (WES), and targeted panels. -
Application of metagenomic sequencing on DNBSEQ-G99 sequencing platform detects a rare psittacosis pathogen.
Chlamydia psittaci causes severe illnesses, often undetected due to vague symptoms and diagnostic limitations. Research shows metagenomic sequencing, particularly with the DNBSEQ-G99 platform, is key for identifying this pathogen and discovering new microbes efficiently. -
Construction of a spatiotemporal transcriptomic atlas of zebrafish embryogenesis using the DNBSEQ-T7 sequencer
Stereo-seq mapped 91 zebrafish embryos across six stages in 24 hours, identifying key gene patterns and interactions, crucial for embryogenesis research. Data was produced using the efficient DNBSEQ-T7 sequencer.